• NewAmsterdam Pharma Chief Accounting Officer Louise Frederika Kooij reported option exercises, acquiring 105,000 ordinary shares on July 20, 2026.
• She sold 104,000 ordinary shares the same day at weighted average prices of USD 29.96, USD 31.05, USD 31.71.
• Her ordinary share holdings fell to 24,353 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-312387), on July 22, 2026, and is solely responsible for the information contained therein.